Pharmacy resident participation with a 24-hour multidisciplinary stroke response team

Pandya, Komal A.; Ruf, Kathryn M.; Winstead, P. Shane; Cook, Aaron M.; Weant, Kyle A.
November 2010
American Journal of Health-System Pharmacy;11/15/2010, Vol. 67 Issue 22, p1901
Academic Journal
The article reports on the use of alteplase, a recombinant tissue plasminogen activator approved by the U.S. Food and Drug Administration, to restrict damage to ischemic stroke patients. It mentions several complications of the therapy which include the bleeding risk, the required intense patient monitoring, and the possibility for major medication errors. Furthermore, the roles of protocol enhancement as well as pharmacy involvement for multidisciplinary stroke response teams are discussed.


Related Articles

  • TPA (Altepase) for Acute Ischemic Stroke.  // ED Nursing;Jan2011 Supplement, p1 

    The article offers guidelines on how to administer Tissue Plasminogen Activator (TPA) to an adult suffering from acute ischemic stroke in the U.S. It states that patient and family must be informed about the intracerebral hemorrhage risk of thrombolytic therapy and must be written on the consent...

  • Lessons learned from a pharmacy practice model change at an academic medical center. Knoer, Scott J.; Pastor III, John D.; Phelps, Pamela K. // American Journal of Health-System Pharmacy;11/1/2010, Vol. 67 Issue 21, p1862 

    Purpose. The development and implementation of a new pharmacy practice model at an academic medical center are described. Summary. Before the model change, decentralized pharmacists responsible for order entry and verification and clinical specialists were both present on the care units. Staff...

  • Return on investment of a pharmacy residency training program. Pasek, Peter A.; Stephens, Carolyn // American Journal of Health-System Pharmacy;11/15/2010, Vol. 67 Issue 22, p1952 

    Purpose. The return on investment of pharmacy residency training at a Veterans Affairs hospital was estimated. Methods. The financial costs and benefits associated with one year's training of eight residents were estimated retrospectively. The costs were compared with estimated costs for...

  • Impact of health information technology on detection of potential adverse drug events at the ordering stage. Roberts, Lance L.; Ward, Marcia M.; Brokel, Jane M.; Wakefield, Douglas S.; Crandall, Donald K.; Conlon, Paul // American Journal of Health-System Pharmacy;11/1/2010, Vol. 67 Issue 21, p1838 

    Purpose. The impact of implementing commercially available health care information technologies at hospitals in a large health system on the identification of potential adverse drug events (ADEs) at the medication ordering stage was studied. Methods. All hospitals in the health system had...

  • Strong red rules and safety cells cut errors.  // Healthcare Risk Management;May2011, Vol. 33 Issue 5, p55 

    No abstract available.

  • Improving Appropriateness of Blood Utilization Through Prospective Review of Requests for Blood Products: The Role of Pathology Residents as Consultants. Haldiman, Lindsey; Zia, Hamid; Singh, Gurmukh // Laboratory Medicine;Summer2014, Vol. 45 Issue 3, p264 

    Objective: To evaluate the effectiveness of prospective review of orders for fresh-frozen plasma (FFP) and platelets in reducing blood-product use, and of the effectiveness of preparing pathology residents to serve as clinical consultants. Design: At our 572-bed tertiary-care hospital, we...

  • Hyper-acute stroke treatment: the first 48 hours. Nazarko, Linda // British Journal of Healthcare Assistants;Oct2013, Vol. 7 Issue 10, p486 

    Every year, 150 000 people in the UK suffer a stroke. This works out at one every five minutes (Townsend et al, 2012). Stroke is the single largest cause of disability and the third largest cause of deaths in England. Stroke costs the NHS over £2.8 billion and can lead to death or severe...

  • Stroke busters. Schrof, Joannie M.; Egan, Jack // U.S. News & World Report;03/15/99, Vol. 126 Issue 10, p62 

    Examines the diagnosis and treatment of stroke. Number of people in the United States who suffer strokes; Development of a new stroke drug called TPA (tissue plasminogen activator); Small percentage of stroke victims making it to the hospital in time to be treated; Effectiveness of TPA within...

  • Hyper acute stroke unit services. DUDLEY, NIGEL // Clinical Medicine;Oct2011, Vol. 11 Issue 5, p508 

    A letter to the editor is presented in response to an article on hyper acute stroke unit services in June 2011 issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics